Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	1 Months Ended	5 Months Ended	6 Months Ended
	Feb. 02, 2021	Jun. 30, 2021	Jun. 30, 2022
Cash flows from operating activities:
Net income (loss)	$ 268,777	$ (87,629)	$ 67,344
Adjustments to reconcile net income (loss) to net cash from operating activities:
Depreciation, depletion, amortization and accretion	10,499	130,404	57,431
Deferred income taxes	54,322	(16,295)	1,687
Amortization of credit facility costs	0	0	254
Stock based compensation expense	935	1,570	1,543
Reorganization items, net	(354,279)	0	0
Bad debt	(210)	(5,433)	(920)
Gain on sale of assets and businesses	58	0	0
Gain on sale of equity securities	0	0	(3,611)
Unrealized gain on investment in equity securities	0	0	(544)
Other (gains) and losses, net	0	7,883	(23,296)
Other reconciling items, net	1,017	(1,886)	2,529
Changes in operating assets and liabilities:
Accounts receivable	3,602	(12,518)	(26,362)
Prepaid expenses	(340)	(2,910)	(2,652)
Inventory and other current assets	(221)	7,314	(5,358)
Accounts payable	(2,365)	9,619	(1,986)
Accrued expenses	23,489	(25,604)	144
Income taxes	340	13,805	2,185
Other, net	(241)	(5,817)	(144)
Net cash from operating activities	5,383	12,503	68,244
Cash flows from investing activities:
Payments for capital expenditures	(3,035)	(10,995)	(20,514)
Proceeds from sales of assets	775	16,200	15,183
Proceeds from sales of equity securities	0	0	13,366
Net cash from investing activities	(2,260)	5,205	8,035
Cash flows from financing activities:
Credit facility costs	(1,920)	(14)	0
Tax withholdings for vested restricted stock units	0	(1,485)	0
Net cash from financing activities	(1,920)	(1,499)	0
Effect of exchange rate changes on cash	311	0	0
Net change in cash, cash equivalents, and restricted cash	1,514	16,209	76,279
Cash, cash equivalents, and restricted cash at beginning of period		269,698	394,535
Cash, cash equivalents, and restricted cash at end of period	$ 269,698	$ 285,907	$ 470,814